Genes and pathways downstream of telomerase in melanoma metastasis
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
Recent studies have demonstrated a role for telomerase in driving tumor progression, but its mechanism of action remains unclear. Here we show that stable, ribozyme-mediated suppression of mouse telomerase RNA reduced telomerase RNA expression, telomerase activity, and telomere length, which significantly reduced tumor invasion and metastatic potential. Our studies reveal that previously unidentified effects of telomerase may mediate its tumor-promoting effects. First, reducing telomerase activity induced a more dendritic morphology, accompanied by increased melanin content and increased expression of tyrosinase, a key enzyme in melanin biosynthesis. Second, gene expression profiling revealed that telomerase targeting down-regulated expression of several glycolytic pathway genes, with a corresponding decrease in glucose consumption and lactate production. Thus, telomerase activity controls the glycolytic pathway, potentially altering the energy state of tumor cells and thereby modulating tyrosinase activity and melanin production. These studies have important implications for understanding the mechanisms by which telomerase promotes tumor invasion and metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, an inverse correlation with the length of telomeres was shown for the development of cardiovascular disease [44-47], renal failure [48, 49], various cancers [50, 51], Alzheimer's disease [52], and Parkinson's disease [53].”
From Markers of cellular senescence. Telomere shortening as a marker of cellular senescence (2016) · cites this paper as [51]
Citations
Cites
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citationAkt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Telomere states and cell fates
Blackburn, E. H. (2000) · Nature · doi:10.1038/35040500 · Cited by 1,377
Self-citationGreider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150
Self-citationInhibition of telomerase limits the growth of human cancer cells
Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M., & Weinberg, R. A. (1999) · Nature Medicine · doi:10.1038/13495 · Cited by 1,030
Telomeres: Beginning to Understand the End
Zakian, V. A. (1995) · Science · doi:10.1126/science.270.5242.1601 · Cited by 852
Kang, S. S., Kwon, T., Kwon, D. Y., & Do, S. I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13085 · Cited by 480
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation
Gupta, P. B., Kuperwasser, C., Brunet, J.-P., Ramaswamy, S., Kuo, W.-L., Gray, J. W., Naber, S. P., & Weinberg, R. A. (2005) · Nature Genetics · doi:10.1038/ng1634 · Cited by 439
The gene expression signatures of melanoma progression
Haqq, C., Nosrati, M., Sudilovsky, D., Crothers, J., Khodabakhsh, D., Pulliam, B. L., Federman, S., Miller, J. R., Allen, R. E., Singer, M. I., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501564102 · Cited by 433
Self-citationTelomerase contributes to tumorigenesis by a telomere length-independent mechanism
Stewart, S. A., Hahn, W. C., O'Connor, B. F., Banner, E. N., Lundberg, A. S., Modha, P., Mizuno, H., Brooks, M. W., Fleming, M., Zimonjic, D. B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182407599 · Cited by 431
Telomerase: A target for cancer therapeutics
Shay, J. W., & Wright, W. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00159-9 · Cited by 339
Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase
Lay, A. J., Jiang, X.-M., Kisker, O., Flynn, E., Underwood, A., Condron, R., & Hogg, P. J. (2000) · Nature · doi:10.1038/35048596 · Cited by 267
Halaban, R., Cheng, E., Zhang, Y., Moellmann, G., Hanlon, D., Michalak, M., Setaluri, V., & Hebert, D. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6210 · Cited by 257
Expression of small, therapeutic RNAs in human cell nuclei
Good, P., Krikos, A., Li, S., Bertrand, E., Lee, N., Giver, L., Ellington, A., Zaia, J., Rossi, J., & Engelke, D. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300354 · Cited by 225
Self-citationClinical utility of telomerase in cancer
Hiyama, E., & Hiyama, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205070 · Cited by 202
Li, S., Rosenberg, J. E., Donjacour, A. A., Botchkina, I. L., Hom, Y. K., Cunha, G. R., & Blackburn, E. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0953 · Cited by 194
Self-citationChang, S., Khoo, C. M., Naylor, M. L., Maser, R. S., & DePinho, R. A. (2003) · Genes & Development · doi:10.1101/gad.1029903 · Cited by 183
Abnormal Acidification of Melanoma Cells Induces Tyrosinase Retention in the Early Secretory Pathway
Halaban, R., Patton, R. S., Cheng, E., Svedine, S., Trombetta, E. S., Wahl, M. L., Ariyan, S., & Hebert, D. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111497200 · Cited by 162
Li, S., Crothers, J., Haqq, C. M., & Blackburn, E. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502782200 · Cited by 158
Self-citationLudwig, A., Saretzki, G. C., Holm, P. S., Tiemann, F., Lorenz, M., Emrich, T., Harley, C. B., & von Zglinicki, T. (2001) · PubMed · doi:10.25405/ncl.34663959 · Cited by 138
Zhang, W., Piatyszek, M. A., Kobayashi, T., Estey, E. H., Andreeff, M., Deisseroth, A., Wright, W. E., & Shay, J. W. (1996) · PubMed · Cited by 116
Saretzki, G. C., Ludwig, A., von Zglinicki, T., & Runnebaum, I. B. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700383 · Cited by 112
Halaban, R., Cheng, E., Svedine, S., Aron, R., & Hebert, D. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008703200 · Cited by 90
Telomerase as a therapeutic target for malignant gliomas
Komata, T., Kanzawa, T., Kondo, Y., & Kondo, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205072 · Cited by 85
Autocrine Motility Factor Signaling Enhances Pancreatic Cancer Metastasis
Tsutsumi, S., Yanagawa, T., Shimura, T., Kuwano, H., & Raz, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1015 · Cited by 81
Telomeres and cancer: a tale with many endings
Blasco, M. A. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00011-4 · Cited by 62
Kashani–Sabet, M., Liu, Y., Fong, S., Desprez, P., Liu, S., Tu, G., Nosrati, M., Handumrongkul, C., Liggitt, D., Thor, A. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.002025599 · Cited by 53
Self-citationAssembly, Verification, and Initial Annotation of the NIA Mouse 7.4K cDNA Clone SetPreprint
VanBuren, V., Piao, Y., Dudekula, D. B., Qian, Y., Carter, M. G., Martin, P. R., Stagg, C. A., Bassey, U. C., Aiba, K., Hamatani, T., et al. (2002) · Genome Research · doi:10.1101/gr.633802 · Cited by 49
Suppression of the Malignant Phenotype of Melanoma Cells by Anti-Oncogene Ribozymes
Ohta, Y., Kijima, H., Kashani‐Sabet, M., & Scanlon, K. J. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12340688 · Cited by 46
Self-citationAntitumor Activity of Systemically Delivered Ribozymes Targeting Murine Telomerase RNA
Nosrati, M., Li, S., Bagheri, S., Ginzinger, D. G., Blackburn, E. H., Debs, R. J., & Kashani–Sabet, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0134 · Cited by 45
Self-citationLiu, L., Berletch, J. B., Green, J. G., Pate, M. S., Andrews, L. G., & Tollefsbol, T. O. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1003.3.8 · Cited by 38
Research works printed but not linked: 3
- A. Ludwig, G. Saretzki, P. S. Holm, F. Tiemann, M. Lorenz, T. Emrich Cancer Res. 61, 3053–3061 (2001).
- S. S. Kang, T. Kwon, D. Y. Kwon, S. I. Do J. Biol. Chem. 274, 3085–3090 (1999).
- W. Zhang, M. A. Piatyszek, T. Kobayashi, E. Estey, M. Andreeff, A. B. Deisseroth, W. E. Wright, J. W. Shay Clin. Cancer Res. 2, 799–803 (1996).
Cited by
Seyfried, T. N., & Shelton, L. M. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-7 · Cited by 644
Targeting telomeres and telomerase
De Cian, A., Lacroix, L., Douarre, C., Temime-Smaali, N., Trentesaux, C., Riou, J.-F., & Mergny, J.-L. (2008) · Biochimie · doi:10.1016/j.biochi.2007.07.011 · Cited by 572
Ahmed, S., Passos, J. F., Birket, M. J., Beckmann, T., Brings, S., Peters, H., Birch-Machin, M. A., von Zglinicki, T., & Saretzki, G. (2008) · Journal of Cell Science · doi:10.1242/jcs.019372 · Cited by 491
Markers of cellular senescence. Telomere shortening as a marker of cellular senescence
Bernadotte, A., Mikhelson, V. M., & Spivak, I. M. (2016) · Aging · doi:10.18632/aging.100871 · Cited by 466
DNA damage in telomeres and mitochondria during cellular senescence: is there a connection?
Passos, J. F., Saretzki, G., & von Zglinicki, T. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm893 · Cited by 344
Metadata
- Authors
- Bagheri, S., Nosrati, M., Li, S., Fong, S., Torabian, S., Rangel, J., Moore, D. H., Federman, S., LaPosa, R. R., Baehner, F. L., Sagebiel, R. W., Cleaver, J. E., Haqq, C., Debs, R. J., Blackburn, E. H., & Kashani-Sabet, M.
- Affiliations
- University of California, San Francisco (US)
- California Pacific Medical Center (US)
- *Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, Comprehensive Cancer Center, and Department of Dermatology, University of California, San Francisco, CA 94115;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-07-25
- Volume
- 103
- Issue
- 30
- Pages
- 11306-11311
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1544082
- OpenAlex
- W1969066171
- Cited by
- 129
- References
- 35
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 6 · 2016: 16 · 2015: 9 · 2014: 11 · 2013: 7 · 2012: 10
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Damon Runyon Cancer Research Foundation
- National Cancer Institute (R01CA114337, R01CA096666, CA96840, CA96666, R01CA096840, CA114337)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R03AR049378)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- telomerase, melanoma, metastasis, tumor invasion, telomerase RNA, ribozyme knockdown, telomere length, tyrosinase, melanogenesis, glycolysis, glucose metabolism, lactic acid production, tumor cell morphology, downstream signaling pathways
- MeSH terms
- Animals, Cell Differentiation, Glucose, Lactates, Melanins, Melanoma, Melanoma, Experimental, Mice, Inbred C57BL, Neoplasm Invasiveness, Neoplasm Metastasis, Monophenol Monooxygenase, Gene Expression Regulation, Neoplastic, Telomerase, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.